[Expression of tissue factor induced by IL-6 in HUVEC]

Area of Science:

• Endothelial cell biology
• Molecular biology
• Immunology

Context:

• Interleukin-6 (IL-6) is a pro-inflammatory cytokine implicated in various physiological and pathological processes.
• Tissue Factor (TF) is a key initiator of the extrinsic coagulation cascade.
• Understanding the interplay between IL-6 and TF in endothelial cells is crucial for elucidating mechanisms of thrombosis and inflammation.

Purpose:

• To investigate the effect of IL-6 on the expression of tissue factor (TF) mRNA in human umbilical vein endothelial cells (HUVECs).
• To determine the time course and impact on cell viability of IL-6-induced TF expression.

Summary:

• HUVECs were treated with IL-6 (0.5 ng/mL), and cell viability was assessed using CCK-8 assay.
• Tissue factor mRNA levels were quantified using reverse transcriptase-polymerase chain reaction (RT-PCR).
• IL-6 treatment did not significantly alter HUVEC viability over 72 hours. TF mRNA expression was upregulated by IL-6, peaking at 12 hours and detectable between 6 and 48 hours, but absent after 72 hours.

Impact:

• IL-6 does not directly affect HUVEC viability at the tested concentration.
• IL-6 significantly induces TF mRNA expression in HUVECs, suggesting a role in modulating blood coagulation.
• These findings contribute to understanding the molecular mechanisms underlying coagulation system dysregulation in inflammatory conditions.